Agibot

Agibot Medtech (Suzhou) Co., Ltd. ("Agibot" for short) was founded in 2020 with the vision of "Creating the Future of Intelligent Surgery." It is a high-tech enterprise focused on the innovative research, development, and industrialization of surgical robots. The company's R&D and office centers are located in Dushu Lake Science and Education Innovation District of Suzhou Industrial Park and Zhangjiang High-Tech Park in Shanghai, while its production base is situated in Wujiang Economic and Technological Development Zone in Suzhou.Agibot concentrates on precision diagnosis and treatment of benign and malignant diseases across multiple human body systems, building its product pipeline around endoscopic surgical robots and natural orifice surgical robots. Members of the founding team are all veterans in the field of surgical robotics, possessing extensive experience in new product development and commercial operation. Agibot has assembled an R&D project team composed of professionals from top industry companies and renowned universities both domestically and internationally, specializing in medicine, mechanics, optics, electronics, algorithms, and software, as well as an operations management team comprising numerous seasoned industry experts. Agibot has successfully completed an angel round of financing worth tens of millions of yuan. Its product development is proceeding steadily with rapid iteration, and the team size continues to grow, striving to provide clinically innovative and accessible intelligent surgical solutions.